LYB
22
2
F
54
2
XYL
68
2
EW
44
3
EMN
53
4
RCL
88
3
STZ
40
3
STX
85
10
AEE
74
5
NEE
70
2
PH
80
2
TRV
50
5
EMC
87
14
AVGO
70
-3
CPB
44
4
FRT
60
2
L
55
9
CAG
41
2
ZTS
33
2
CSCO
74
7
LYB
22
2
F
54
2
XYL
68
2
EW
44
3
EMN
53
4
RCL
88
3
STZ
40
3
STX
85
10
AEE
74
5
NEE
70
2
PH
80
2
TRV
50
5
EMC
87
14
AVGO
70
-3
CPB
44
4
FRT
60
2
L
55
9
CAG
41
2
ZTS
33
2
CSCO
74
7
Financhill
Back

InfuSystems Holdings 10K Form

Sell
30

INFU
InfuSystems Holdings

Last Price:
$6.12
Seasonality Move:
-2.7%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive INFU News And Ratings

See the #1 stock for the next 7 days that we like better than INFU

INFU Financial Statistics

Sales & Book Value

Annual Sales: $134.9M
Cash Flow: $-1.6M
Price / Cash Flow: 57.9
Annual Sales: $2.63
Price / Book: 2.34

Profitability

EPS (TTM): 0.14000
Net Income (TTM): $3.2M
Gross Margin: $70.4M
Return on Equity: 5.82%
Return on Assets: 3.03%

InfuSystems Holdings Earnings Forecast

Key InfuSystems Holdings Financial Ratios

  • The Gross Profit Margin over the past 18 years for INFU is 52.20%.
  • The Selling, General & Administrative Expenses for INFU have been equal to 46.36% of Gross Profit Margin.
  • The Interest Expense is 75.78% of Operating Income.
  • The Net Earning history of INFU is 1.74% of Total Revenues.
  • Per Share Earnings over the last 20 years have been positive in 10 years.

InfuSystems Holdings Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYAM
Industry: Health Care Providers & Services
Sector: Health Care
Current Symbol: INFU
Website: infusystem.com

Debt

Debt-to-Equity Ratio: 0.52
Current Ratio: 2.21
Quick Ratio: 1.59

Price-to-Earnings

Trailing P/E Ratio: 55.91
Forward P/E Ratio: 14.13

INFU Technical Analysis vs Fundamental Analysis

Sell
30
InfuSystems Holdings (INFU) is a Sell

Is InfuSystems Holdings a Buy or a Sell?